The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Differences among techniques for high‐abundant protein depletion
Abstract
The need to identify protein or peptide biomarkers via readily available biological samples like serum, plasma, or cerebrospinal fluid is often hindered by a few particular proteins present at relatively high concentrations. The ability to remove these proteins specifically, reproducibly, and with high selectivity is increasingly important in proteomic studies, and success in this procedure is leading to an ever‐increasing list of lower abundant proteins being identified in these biological fluids. The current work addresses some of the potential problems in depleting proteins in typical biomarker studies, including nonspecific binding during depletion procedures and whether low molecular weight (LMW) species bind to the column in a so‐called “sponge” effect caused by the ability of albumin or other high‐abundant proteins to bind peptides or protein fragments. LC‐MS/MS methods were applied to the comparative analysis of an IgG‐based immunodepletion method and a Cibacron blue (CB)‐dye‐based method, for specificity of removing targeted proteins (binding fraction), as well as for assessing efficiency of target removal. This analysis was extended to examine the effects of repeated use of materials (cycles of binding and elution), in order to assess potential for carryover of one sample to the next. Capacity studies and efficiency of protein removal from the serum samples were followed for the IgG‐based system using both immunochemical assays (ELISA) as well as LC‐MS/MS methods. Additionally, the IgG‐based system was further characterized for the removal of LMW polypeptides by nonspecific binding. We conclude that the IgG‐based system provided effective removal of targeted proteins, with minimal carryover, high longevity, and minimal nonspecific binding. Significant differences are noted between the depletion techniques employed, and this should be considered based on the expectations set during experimental design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical diagnosis and management by laboratory methods
Henry, J. B. (1979) · Medical Entomology and Zoology · Cited by 1,691
Björhall, K., Miliotis, T., & Davidsson, P. (2005) · PROTEOMICS · doi:10.1002/pmic.200400900 · Cited by 384
Pieper, R., Su, Q., Gatlin, C. L., Huang, S., Anderson, N. L., & Steiner, S. (2003) · PROTEOMICS · doi:10.1002/pmic.200390057 · Cited by 356
Echan, L. A., Tang, H., Ali‐Khan, N., Lee, K., & Speicher, D. W. (2005) · PROTEOMICS · doi:10.1002/pmic.200401228 · Cited by 353
SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer
Petricoin, E. F., & Liotta, L. A. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.01.005 · Cited by 331
An investigation into the human serum “interactome”
Zhou, M., Lucas, D. A., Chan, K. C., Issaq, H. J., Petricoin, E. F., Liotta, L. A., Veenstra, T. D., & Conrads, T. P. (2004) · ELECTROPHORESIS · doi:10.1002/elps.200405866 · Cited by 313
Yang, Z., & Hancock, W. S. (2004) · Journal of Chromatography A · doi:10.1016/j.chroma.2004.08.150 · Cited by 282
Clinical Diagnosis and Management by Laboratory Methods
Arkin, C. F. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/106.6.799 · Cited by 233
Biomarker discovery and validation: technologies and integrative approaches
Ilyin, S. E., Belkowski, S. M., & Plata-Salamán, C. R. (2004) · Trends in Biotechnology · doi:10.1016/j.tibtech.2004.06.005 · Cited by 195
Chromy, B. A., Gonzales, A. D., Perkins, J., Choi, M. W., Corzett, M. H., Chang, B. C., Corzett, C. H., & McCutchen-Maloney, S. L. (2004) · Journal of Proteome Research · doi:10.1021/pr049921p · Cited by 190
The use of gene-specific IgY antibodies for drug target discovery
Zhang, W. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02655-2 · Cited by 106
Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry
Maccarrone, G., Milfay, D., Birg, I., Rosenhagen, M. C., Holsboer, F., Grimm, R., Bailey, J. M., Zolotarjova, N. I., & Turck, C. W. (2004) · Electrophoresis · doi:10.1002/elps.200305909 · Cited by 94
Self-citationSeparation Methods In Proteomics
(2005) · CRC Press eBooks · doi:10.1201/9781420028058 · Cited by 74
Prestera, T., Prochaska, H. J., & Talalay, P. (1992) · Biochemistry · doi:10.1021/bi00118a027 · Cited by 59
Ogata, Y., Charlesworth, M. C., & Muddiman, D. C. (2005) · Journal of Proteome Research · doi:10.1021/pr049750o · Cited by 58
Cited by
Omenn, G. S., States, D. J., Adamski, M., Blackwell, T. W., Menon, R., Hermjakob, H., Apweiler, R., Haab, B. B., Simpson, R. J., Eddes, J. S., et al. (2005) · PROTEOMICS · doi:10.1002/pmic.200500358 · Cited by 787
Human body fluid proteome analysis
Hu, S., Loo, J. A., & Wong, D. T. (2006) · PROTEOMICS · doi:10.1002/pmic.200600284 · Cited by 533
Proteome-based plasma biomarkers for Alzheimer's disease
Hye, A., Lynham, S., Thambisetty, M., Causevic, M., Campbell, J., Byers, H. L., Hooper, C., Rijsdijk, F., Tabrizi, S. J., Banner, S., et al. (2006) · Brain · doi:10.1093/brain/awl279 · Cited by 464
Liu, T., Qian, W.-J., Gritsenko, M. A., Camp, D. G., Monroe, M. E., Moore, R. J., & Smith, R. D. (2005) · Journal of Proteome Research · doi:10.1021/pr0502065 · Cited by 405
Depletion of Abundant Plasma Proteins and Limitations of Plasma Proteomics
Tu, C., Rudnick, P. A., Martinez, M. Y., Cheek, K. L., Stein, S. E., Slebos, R. J. C., & Liebler, D. C. (2010) · Journal of Proteome Research · doi:10.1021/pr100646w · Cited by 390
Metadata
- Authors
- Zolotarjova, N., Martosella, J., Nicol, G., Bailey, J., Boyes, B. E., & Barrett, W. C.
- Venue
- PROTEOMICS
- Publisher
- Wiley
- Published
- 2005-08
- Volume
- 5
- Issue
- 13
- Pages
- 3304-3313
- ISSN
- 1615-9853 (ISSN-L)
- 1615-9861
- OpenAlex
- W2024720397
- Cited by
- 282
- References
- 15
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.